Ground News

Don't Just Read the News, Understand It.

Neuroendocrine Cancer UK image

News from Neuroendocrine Cancer UK

Stay current with all the latest and breaking news from Neuroendocrine Cancer UK. Compare headlines and media bias behind news outlets on stories breaking today.

We’ve discovered 7 headlines written by Neuroendocrine Cancer UK during the past 3 months.

The Ground News media bias check for Neuroendocrine Cancer UK is unknown. Scores are assigned by aggregating bias scores from Ad Fontes Media, Media Bias/Fact Check, and All Sides.

Neuroendocrine Cancer UK’s factuality rating is Unknown. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about Neuroendocrine Cancer UK

Where is Neuroendocrine Cancer UK located?Neuroendocrine Cancer UK's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Neuroendocrine Cancer UK News

Breakthrough Research Paves Way for Personalised Treatment in Lung Neuroendocrine Cancer

Queensland, Australia · Queensland

Breakthrough Research Paves Way for Personalised Treatment in Lung Neuroendocrine Cancer

Breakthrough lung research advances personalised treatment for Lung neuroendocrine cancer, offering new hope with a simple tool to guide targeted therapies.See the Story

Advocacy & Policy Updates

Advocacy & Policy Neuroendocrine Cancer UK was founded with the vision of providing support, raising awareness, and driving research for those affected by neuroendocrine cancer. What started as a small community initiative has now grown into a leading charity that advocates and campaigns for patients and their families across the UK. We believe it is vital that our community should be included early on in critical conversations about research pr…Cancer · United Kingdom Read Article

Health-related social needs can lead to missed cancer imaging

Health-related social needs can lead to missed imaging appointments among cancer patients.Mental Health · United Kingdom See the Story

Selective internal radiation therapy (SIRT) Update

Following on from our earlier News Item - and given the degree of interest this topic has generated on our social media platforms and Facebook Forums; we hope that this update will provide further clarity and information. SIRT is a potential option for neuroendocrine tumours (NETs) that have spread to the liver: it does NOTFacebook · England Read Article

Cabozantinib gains FDA approval for treating advanced neuroendocrine tumors

100% Center coverage: 1 sources

Cabozantinib, an oral tyrosine kinase inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with previously treated advanced neuroendocrine tumors (NETs).Medical · United States See the Story

FDA OKs Cabozantinib for Pancreatic Neuroendocrine Tumors

Approval was based on findings from the pivotal CABINET trial showing improved PFS and response rates vs placebo. Medscape Medical NewsMedical · United States See the Story

You've scrolled to the bottom of the feed, there are no more stories.